Predictive Oncology appoints Pamela Bush as Chief Business Officer

Axe Compute Inc.

Pamela Bush, Ph.D., MBA, appointed Chief Business Officer effective Jan. 30, 2023.
Bush previously served as SVP of Strategic Sales and Business Development since Dec. 2021.
She brings 20+ years experience in life sciences venture creation and business development.
Prior roles include Director of Corporate Business Development at Eli Lilly & Company.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Pamela Bush

Chief Business Officer

AGPU · Axe Compute Inc.

Effective: 2023-01-30
Filed: February 3, 2023, 6:59 PM ET

On January 30, 2023, the Board of Directors of Predictive Oncology Inc. (the “Company”) appointed Pamela Bush, Ph.D., MBA, age 49, as Chief Business Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Pamela Bush was appointed as Chief Business Officer at Axe Compute Inc..

Action: appointed
Role: Chief Business Officer

Exact text from the filing

On January 30, 2023, the Board of Directors of Predictive Oncology Inc. (the “Company”) appointed Pamela Bush, Ph.D., MBA, age 49, as Chief Business Officer.

View on SEC.gov

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-23-000659

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.